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Background:  Diabetes is a major health problem in Korea. However, interest in the quality of life in patients with diabetes is low. 
We examined the effects of diabetes on health-related quality of life (HRQoL) and compared it with HRQoL in the general Kore-
an population using the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV) (2007–2009).
Methods:  Using KNHANES IV data, we compared EuroQol (EQ)-5D and EQ-visual analogue scale (VAS) scores after adjust-
ing for sociodemographic and psychosocial factors as well as for comorbidities (hypertension, heart disease, stroke, arthritis, and 
chronic renal disease). Logistic regressions were used to explore determinants for the lowest quintile HRQoL scales in the diabe-
tes group.
Results:  The mean age of the 14,441 enrolled subjects (6,129 men and 8,312 women) was 52.5±14.5 years. The mean EQ-5D 
and EQ-VAS scores were significantly lower in the diabetes group (EQ-5D. 0.87; EQ-VAS, 71.94) than in the non-diabetes group 
(EQ-5D, 0.94; EQ-VAS, 77.40) (P<0.001). Self-reported depressive symptom had a significant effect on lowering the EQ-VAS 
(odds ratio [OR], 1.7; 95% confidence interval [CI], 1.1 to 2.6) in the diabetes group. Stress level had a significant effect in lower-
ing both the EQ-5D (OR, 2.0; 95% CI, 1.3 to 2.9) and the EQ-VAS (OR, 1.9; 95% CI, 1.3 to 2.9). HbA1c, diabetes duration, and 
treatment modalities had no significant effect on lowering HRQoL.
Conclusion:  Diabetes was clearly associated with impaired HRQoL compared with the non-diabetic population regardless of 
comorbidities. Therapeutic approaches should focus much more on the subjective perception of health in patients with diabetes.
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INTRODUCTION
Diabetes is not yet a curable disease. Dietary restrictions, medi-
cations including insulin injections, and diabetes-associated 
morbidities seriously deteriorate the quality of life (QoL) of 
patients with diabetes [1]. The World Health Organization de-
fines health as not only the absence of disease and infirmity, 
but also the presence of physical, mental, and social well-being 
[2]. If the purpose of medicine is to make patients healthy, the 
aim of diabetes treatment should not be limited to controlling 
glycemia, and more focus should be placed on improving QoL 
for patients with diabetes. 
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  Many recent studies have reported on health-related quality 
of life (HRQoL) in diabetes patients. HRQoL is poorer in pa-
tients with diabetes than in the general population [2,3]. A re-
cent multinational study showed that diabetes has a notable 
impact on general health [4], and poor HRQoL in patients with 
diabetes is associated with adverse outcomes, including in-
creased mortality [5].
  Diabetes is a major health problem in Korea. The prevalence 
of diabetes was estimated to be 9.1% in 2005 [6] with a diabe-
tes-related mortality rate of 24.5 per 100,000 persons in 2005, 
which is double that of a decade earlier [7]. Although there is 
growing interest in diabetes, interest in the QoL of patients with 
diabetes is relatively low, and few studies have reported on 
HRQoL in Korean patients with diabetes. In the present study, 
we examined the effects of diabetes on HRQoL and compared 
it with HRQoL in the general Korean population using data 
from the Fourth Korea National Health and Nutrition Exami-
nation Survey (KNHANES IV) (2007–2009).
 
METHODS
The Ministry of Health and Welfare of Korea began conduct-
ing KNHANES in 1998 to examine the general health and nu-
tritional status of Koreans [6,8]. KNHANES IV was conducted 
from July 2007 to December 2009. The survey used a stratified 
multistage probability sampling design for the South Korean 
population and a two-stage stratified systematic sampling meth-
od. Clusters of households were selected from each district, each 
including an average of 20 to 23 households. KNHANES con-
sists of four different measures: a health interview, a health be-
havior survey, a health examination, and a nutrition survey. In 
KNHANES IV, 31,705 individuals aged >1 year were sampled 
by the health interview and examination (6,455 in 2007, 12,528 
in 2008, and 12,722 in 2009); these individuals represented 
9,421 households in 200 districts (1,739 in 2007, 3,707 in 2008, 
and 3,975 in 2009). From the initial 31,705 individuals sam-
pled, 24,871 participated in the survey (4,594 in 2007, 9,744 in 
2008, and 10,533 in 2009), for a response rate of 78.4% (71.2% 
in 2007, 77.8% in 2008, and 82.8% in 2009). In the present study, 
we analyzed data from 14,441 subjects aged ≥30 years (6,129 
men and 8,312 women), after excluding 1,461 individuals (964 
non-respondents on diabetes status and EuroQol [EQ]-5D, 
497 participants who had a cancer history). We excluded sub-
jects with a history of malignancy because malignancies have 
obvious deleterious effects on QoL.
Presence of diabetes and measurement of QoL
The presence of diabetes was based on a self-reported question-
naire asking if the participants had ever been diagnosed with 
diabetes; undiagnosed patients who reported diabetes on the 
health examination survey were not included in this study be-
cause we assumed that self-perceived diabetes itself could af-
fect HRQoL. Participants with diabetes were asked what year 
they were diagnosed and what treatment modalities they had 
experienced (no care, lifestyle modifications, oral hypoglyce-
mic agents, and insulin). We calculated the duration of diabe-
tes using the year of diabetes diagnosis and divided partici-
pants into groups based on that number: ≤10 years, 10 to 20 
years, and ≥20 years.
  The EuroQol was used evaluate HRQoL. The EuroQol con-
sists of two parts, the health-status descriptive system (EQ-5D) 
and a visual analogue scale (EQ-VAS). The EQ-5D records the 
level of self-reported problems according to five dimensions 
(mobility, self-care, usual activities, pain/discomfort, and anx-
iety/depression) [9,10]. Each of the dimensions is assessed 
based on a single question with three response levels (no prob-
lems, some problems, and extreme problems). Using a combi-
nation of these items, a single health index score was calculat-
ed using the Korea valuation set developed by the Korean 
Centers for Disease Control and Prevention [11]. Scores on 
the EQ-5D index range from -0.171 to 1, where 1 indicates no 
problems in any of the five dimensions, zero indicates death, 
and negative values indicate a health status worse than death. 
Next, respondents described their own health status using a 
VAS ranging from 0 (worst imaginable health) to 100 (best 
imaginable health) [10].
Covariates
Participants were requested to provide information on house-
hold income (divided into quartiles), education level, current 
job status (employed or not), marital status (single, married, 
divorced, widow, or widower), current smoker (yes or no), fre-
quency of alcohol consumption per week (more than or less 
than twice per week), level of psychological stress (none, low, 
moderate, extreme), continuous depressive symptoms during 
the past 2 weeks (yes or no). Participants also reported wheth-
er they had ever had comorbidities including malignancies, 
hypertension, heart diseases (acute myocardial infarction or 
angina), stroke, arthritis, and/or chronic renal disease. 589
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Glycated hemoglobin (HbA1c) measurements
Subjects were instructed to fast after 7 PM on the day before 
blood sampling and to drink only bottled water after 7 PM 
The next morning, blood (2 mL) was collected from each par-
ticipant into a NaF container. Samples were properly processed, 
refrigerated, and transported in cold storage to the Central 
Testing Institute at Seoul, Korea on the same day. HbA1c was 
measured using high-performance liquid chromatography. 
We divided HbA1c results into three categories (≤6.5%, 6.5% 
to 8.0%, and ≥8.0%). 
Statistical analysis
All sample and weight variables were stratified, and the PASW 
complex-samples procedure was used for all statistical analy-
ses. We used the stratification variables and sampling weights 
designated by the Korean Centers for Disease Control and 
Prevention for prevalence calculations, which were based on 
the sample design for each survey year. Sampling weights were 
adjusted for non-response according to demographic factors 
after the surveys were completed. The frequencies procedure 
was performed with cluster as a sampling-district variable, and 
prevalence was reported with a 95% confidential interval (CI). 
The descriptive procedure was used to evaluate the distribu-
tion of sociodemographic and clinical variables and QoL mea-
surements. The crosstabs procedure was used to compare cat-
egorical or ordinal variables in participants with and without 
diabetes. The general linear model was used to compare con-
tinuous variables. Additionally, a sensitivity analysis was used 
to determine whether including undiagnosed patients with 
diabetes in the non-diabetes group would significantly alter 
the HRQoL score. We excluded undiagnosed patients with di-
abetes using the health examination survey in the non-diabe-
tes group and compared the mean EQ-5D and EQ-VAS scores. 
General linear model analyses were also performed using the 
results of the EQ-5D and EQ-VAS for each chronic disease 
(diabetes, hypertension, heart diseases, stroke, arthritis, chron-
ic renal disease) as dependent variables after controlling for 
age, gender, survey year, household income, educational level, 
current job, marital status, current smoking status, frequency 
of alcohol consumption, level of stress, self-reported depres-
sive symptom, and other comorbidities. The survey year was 
also included as a controlled variable because the EQ-5D and 
EQ-VAS scores were significantly different according to survey 
year (data not shown). The EQ-5D and EQ-VAS scales were 
divided into quintiles, and the odd ratios (ORs) of the lowest 
quintile of these scales in the diabetes group were compared 
with those in the non-diabetic group after adjusting for age, 
gender, survey year, household income, educational level, cur-
rent job, marital status, current smoking status, frequency of 
alcohol consumption, stress level, self-reported depressive 
symptoms, and other comorbidities (such as hypertension, 
heart diseases, stroke, arthritis, and chronic renal disease) us-
ing the logistic regression procedure. Four models were con-
structed. The ORs in model 1 were analyzed without adjust-
ment. The ORs in model 2 were adjusted for age and gender. 
In model 3, ORs were further adjusted for survey year, house-
hold income, education level, marital status, percentage of 
current smokers, frequency of drinking, and level of stress and 
self-reported depressive symptom. In model 4, ORs were fur-
ther adjusted for chronic diseases. Subsequently, we also per-
formed subgroup analyses for participants with diabetes. Us-
ing the logistic regression procedure, the ORs of the lowest 
quintile of the EQ-5D and EQ-VAS scales for the level of HbA1c 
(≤6.5%, 6.5% to 8.0%, ≥8.0%), diabetes duration (≤10 years, 
10 to 20 years, ≥20 years), treatment modalities (no care, life-
style modification, oral hypoglycemic agents, insulin), self-re-
ported depressive symptom, the level of stress, and other co-
morbidities were obtained after adjusting for age, gender, sur-
vey year, household income, educational level, current job, 
marital status, current smoking, and the frequency of alcohol 
consumption. All statistical analyses were conducted using 
PASW Statistics version 18.0 (SPSS Inc., Chicago, IL, USA). P 
values of less than 0.05 were considered statistically signifi-
cant.
RESULTS
Of the 14,441 respondents, 1,240 (8.6%) reported that they 
had been diagnosed with diabetes. Characteristics of partici-
pants with and without diabetes are shown in Table 1.
  The mean age for patients with diabetes was significantly 
higher than that of subjects without diabetes. Household in-
come, education level, marital status, employment state, per-
centage of current smokers, and drinking frequency were also 
significantly different between the two groups. The level of 
psychological stress was similar between the two groups; how-
ever, self-reported depressive symptoms were significantly 
higher in the diabetes group than that in the non-diabetes 
group. The prevalence of chronic diseases such as hyperten-
sion, stroke, heart diseases, chronic renal disease, and arthritis 590
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without diabetes (P<0.001). In the sensitivity analysis to de-
termine whether the inclusion of undiagnosed patients with 
diabetes in the non-diabetes group would significantly alter 
the HRQoL score, no significant change was observed (0.87 
vs. 0.94 for EQ-5D, 71.94 vs. 76.95 for EQ-VAS, P<0.01).
  The percentages of subjects who had problems in each scale 
Table 1. Subject characteristics and EQ-5D and EQ-visual analogue scale (VAS) index scores 
Characteristic Diabetes (n=1,240) Non-diabetes (n=13,201) P value
Age, yr  60.1 (59.3-60.9) 48.5 (48.1-48.9) <0.001
Gender, male % 51.8 (48.4-55.2) 49.1 (48.4-49.9) 0.145
Quartile of household income, %
Lowest   31.8 (28.6-35.2) 15.4 (14.3-16.6) <0.001
Lower intermediate   27.4 (24.1-30.9) 24.4 (23.2-25.7)
Higher intermediate  20.5 (17.7-23.5) 29.6 (28.3-30.9)
Highest 20.4 (17.4-23.7) 30.6 (28.7-32.5)
Education level, %
Primary   46.5 (43.1-50.0) 22.8 (21.6-24.1) <0.001
Middle   16.0 (13.6-18.8) 12.2 (11.5-12.9)
High   23.8 (20.9-26.9) 36.1 (34.8-37.4)
College   13.7 (11.4-16.4) 28.9 (27.2-30.6)
Marital status, %
Single   1.2 (0.6-2.2) 5.6 (5.1-6.2) <0.001
Married   75.8 (72.6-78.8) 81.2 (80.1-82.2)
Divorced/widow/widower   23.0 (20.1-26.2) 13.2 (12.4-14.0)
Employed, %  47.8 (44.0-51.6) 64.6 (63.4-65.7) <0.001
Current smoker, %  26.4 (25.6-27.3) 21.3 (18.4-24.4) 0.002
Alcohol consumption (≥2/w), % 21.8 (19.1-24.9) 25.4 (24.4-26.4) 0.034
Level of stress, %
Moderate or extreme 27.5 (24.7-30.5) 28.5 (27.6-29.4) 0.525
None or low 72.5 (69.5-75.3) 71.5 (70.6-72.4)
Depressive symptoms, % 18.7 (16.4-21.2) 14.5 (13.8-15.3) <0.001
Body mass index, kg/m
2 25.1 (24.9-25.3) 23.8 (23.7-23.8) <0.001
Waist circumference, cm 87.6 (87.0-88.3) 81.7 (81.5-82.1) <0.001
Hypertension, % 52.4 (49.0-55.7) 16.9 (16.1-17.7) <0.001
Heart disease, % 6.2 (4.8-7.9) 1.7 (1.5-1.9) <0.001
Chronic renal disease, % 1.8 (1.2-2.7) 0.2 (0.2-0.3) <0.001
Stroke, % 6.5 (5.0-8.4) 1.5 (1.3-1.8) <0.001
Arthritis, % 30.0 (27.0-33.2) 15.5 (14.7-16.3) <0.001
HbA1c, % 7.41 (7.31-7.52) - -
Quality of life
EQ-5D 0.87 (0.86-0.88) 0.94 (0.94-0.94) <0.001
EQ-VAS 71.94 (68.33-75.54) 77.40 (76.18-78.62) <0.001
Values are presented as mean (95% confidence intervals).
was also significantly higher in the diabetes group than in the 
non-diabetic group. The mean EQ-5D index score was 0.87 
(95% CI, 0.86 to 0.88) for those with diabetes and 0.94 (95% 
CI, 0.94 to 0.94) for those without diabetes (P<0.001). The 
mean EQ-VAS score was 71.94 (95% CI, 68.33 to 75.54) for 
those with diabetes and 77.40 (95% CI, 76.18 to 78.62) for those 591
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of the EQ-5D index are shown in Fig. 1. In total, 35.5% of those 
with diabetes had problems with mobility, 11.9% with self-care, 
23.2% with usual activities, 40.2% with pain/discomfort, and 
18.4% with anxiety/depression. For subjects without diabetes, 
the percentages were 13.9%, 3.3%, 9.2%, 25.1%, and 13.1%, re-
spectively. 
  The mean EQ-5D index and EQ-VAS score were signifi-
cantly lower in the diabetes group than in the group without 
diabetes. When we compared the mean EQ-5D index and EQ-
VAS scores after adjusting for socio-demographic and psycho-
social factors and for the presence of chronic diseases using a 
general linear model (Fig. 2), diabetes was still associated with 
deficits in HRQoL, with decreases of 0.013 units on the EQ-
5D index and 4.62 units on the EQ-VAS compared with sub-
jects without diabetes (P<0.05). However, the decreases in 
HRQoL were smaller than those for other chronic diseases 
(heart diseases, stroke, arthritis, and chronic renal disease), 
except hypertension, when controlling for other comorbidities. 
  The ORs for the lowest quintile of the EQ-5D index and 
EQ-VAS score for the diabetes group compared with the non-
diabetes group are shown in Table 2. In model 1, the OR for 
the lowest quintile of the EQ-5D index was 3.20 (95% CI, 2.76 
to 3.72). Even in model 4, after adjusting for other factors in-
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Fig. 1. Distribution of perceived problem levels in each of the dimensions of the EQ-5D descriptive system for the diabetes (DM) 
and non-DM groups. 
aSignificance level between with and without diabetes by chi-square test.
No problems
Some problems
Serious problems
cluding comorbidities, the significance did not change (OR, 
1.27; 95% CI, 1.04 to 1.55). Similarly, the OR for the lowest 
quintile of the EQ-VAS score in model 1 was 2.21. In model 4, 
the OR for the lowest quintile of the EQ-VAS score was 1.52 
(95% CI, 1.28 to 1.81).
  We performed a subgroup analysis for patients with diabe-
tes to examine the impacts of the HbA1c level, diabetes dura-
tion, treatment modalities, presence of depressive symptom, 
stress level, and comorbidities on impaired HRQoL (data not 
shown). The results indicated that HbA1c level, diabetes dura-
tion, and treatment modalities did not have significant effects 
on the HRQoL. Self-reported depressive symptom had a sig-
nificant effect only on lower EQ-VAS (OR, 1.7; 95% CI, 1.1 to 
2.6; P<0.05). However, the level of stress significantly lowered 
both EQ-5D (OR, 2.0; 95% CI, 1.3 to 2.9, P<0.01) and EQ-
VAS (OR, 1.9; 95% CI, 1.3 to 2.9; P<0.01). Among the comor-
bidities tested, only stroke and heart diseases had significant 
effects on both EQ-5D and EQ-VAS. 
DISCUSSION
Our results demonstrated that patients with diabetes had sig-
nificantly lower HRQoL than those without diabetes. Our data 592
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are consistent with previous population-based studies that 
have demonstrated the considerable impact of diabetes on 
lower HRQoL [4,12,13]. Numerous demographic and psycho-
social factors such as age, gender, depressive symptom, and 
psychological stress influence QoL. Diabetic complications are 
among the most important disease-specific determinants of 
QoL [1]. Actually, OR was largely attenuated in models 2, 3, 
and 4 (from 3.20 to 1.27) indicating that differences in age, in-
come, education and diabetes complications play a large role 
in the observed difference in HRQoL. However, we also found 
that HRQoL scores remained low in patients with diabetes 
even after adjusting for many socio-demographic and psycho-
social factors and comorbidities. Therefore, diabetes itself might 
lower HRQoL compared with that in the general population 
regardless of complications and other related factors.
  In this study, patients with diabetes reported better HRQoL 
than did people with a variety of other chronic diseases (such 
as heart disease, stroke, arthritis, and chronic renal disease). 
Previous studies [14-16] have reported that patients suffering 
from stroke or heart disease had lower HRQoL than those 
with diabetes, and HRQoL in those with hypertension was 
higher than that for patients with diabetes [15]. Our finding 
that the HRQoL in Korean patients with diabetes was better 
than that in patients with other diseases was also consistent 
Table 2. Multivariate-adjusted odd ratios for the lowest quintile of the EQ-5D and EQ-visual analogue scale (VAS) scores for the 
diabetes group compared with the non-diabetes group
Model
EQ-5D EQ-VAS
OR (95% CI)
P value
OR (95% CI)
P value
Non-diabetes Diabetes Non-diabetes Diabetes
Model 1 1 3.20 (2.76-3.72) <0.001 1 2.21 (1.91-2.56) <0.001
Model 2 1 1.68 (1.41-1.99) <0.001 1 1.68 (1.44-1.96) <0.001
Model 3 1 1.46 (1.21-1.77) <0.001 1 1.63 (1.38-1.93) <0.001
Model 4 1 1.27 (1.04-1.55) 0.018 1 1.52 (1.28-1.81) <0.001
Model 1, no adjustments; Model 2, adjusted for age and gender; Model 3, adjusted for age, gender, year, household income, education level, 
marital status, occupational status, smoking, alcohol, stress, and presence of depression; Model 4, adjusted for age, gender, year, household in-
come, education level, marital status, occupational status, smoking, alcohol, stress, presence of depression, and other chronic diseases (hyper-
tension, heart diseases, stroke, arthritis, and chronic renal disease).
OR, odds ratio; CI, confidence interval. 
Fig. 2. Multi-variables adjusted means of (A) EQ-5D scores and (B) EQ-visual analogue scale (VAS) according to chronic diseas-
es; diabetes (DM), hypertension (HTN), heart diseases, stroke, and chronic renal failure (CRF). 
aSignificant difference between 
those with and without the chronic disease (P<0.05). 
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with previous studies.
  QoL in patients with diabetes could be affected by various 
factors. Of these factors, we examined diabetes duration, 
HbA1c level, treatment modalities, depressive symptom, psy-
chological stress, and comorbidities in a subgroup analysis of 
patients with diabetes. Our results demonstrated that subjec-
tive factors such as depressive symptom and psychological 
stress affected HRQoL. In contrast, objective factors related to 
diabetic status did not appear to affect HRQoL. In particular, 
HbA1c, an indicator of glycemic control, was not associated 
with impaired HRQoL. Thus, glycemic control itself may not 
necessarily translate to better QoL [17], and a subjective per-
ception of well-being could be more important for the HRQoL 
of patients with diabetes than objective diabetic status.
  There are some preference-based instruments, such as the 
Rosser Index, the 15D, the Quality of Well-Being scale, the 
Health Utility Index (HUI) versions II and III, the EQ-5D, and 
the SF-6D, which are based on the generic SF-36 health survey 
[18]. It has been suggested in some reports that the SF-36-based 
SF6D is more sensitive than the EQ5D in healthy people and 
for detecting small health changes, particularly at the extremes 
of the scale [19,20]. However, in the ADVANCE trial, algo-
rithms based on survey instruments including more compre-
hensive aspects of HRQoL did not appear to measure greater 
variations in utility than those based on simpler instruments 
such as the EQ-5D. Moreover, the EQ-5D is easier to use and 
less time-consuming [21]. Therefore, the EQ-5D has some ad-
vantages, particularly for large population studies such as the 
KNHANES. 
  In this study, the presence of diabetes was based on a self-
reported questionnaire, so the reliability of the diagnosis may 
be arguable. However, the mean HbA1c level for self-reported 
diabetes was 7.41% and showed clear differences between pa-
tients with diabetes and healthy subjects. Moreover, we origi-
nally thought that a subjective perception of disease could be 
more important for HRQoL than an objective diagnosis, and 
the results were not significantly different in the sensitivity 
analysis.
  The strength of our study was that these data were obtained 
from a nationwide population with a high response rate and 
therefore provided representative information on the Korean 
population. Nevertheless, several study limitations should be 
considered. First, although diabetes complications were close-
ly related to individual HRQoL level [1], we did not assess all 
diabetic complications because KNHANES is not a survey only 
for diabetes and does not provide all data related to diabetes 
complications. We did control for other comorbidities, includ-
ing heart diseases (acute myocardial infarction and angina) 
and stroke, which are macrovascular complications, and for 
chronic renal disease, which is a microvascular complication. 
Although it is possible that uncontrolled diabetic complica-
tions could have affected the lower HRQoL observed in the 
diabetic group, the possibility that diabetes itself affects QoL 
still exists regardless of diabetes complications. To examine 
this possibility, further studies on HRQoL in patients with dia-
betes are needed, including a complete investigation of diabet-
ic complications. Second, we did not determine whether the 
patients with diabetes had type 1 or type 2 diabetes. However, 
only 35 patients may have had type 1 diabetes (about 3% among 
all diabetes diagnoses) based on a diagnosis before the age of 
30 years in this survey. Therefore, we considered that most pa-
tients in the study population had type 2 diabetes. Third, we 
could not measure HRQoL using a diabetes-specific quality of 
life tool [22-24] as none have been validated in Korea, and 
only EQ-5D was measured in KNHANES. Studies are needed 
that use disease-specific QoL tools to assess the association 
between diseases and HRQoL [25].
  In conclusion, we found that diabetes was clearly associated 
with impaired HRQoL compared with a population without 
diabetes. This association may be independent of other co-
morbidities. In patients with diabetes, subjective factors such 
as depression and psychological stress, rather than objective 
factors such as glycemic control, were related to impaired 
HRQoL, suggesting that objectively well-controlled diabetes 
does not necessarily translate to a better QoL. Therapeutic ap-
proaches should focus more on the subjective perception of 
health by patients with diabetes, and further studies on HRQoL 
are needed for Korean patients with diabetes. 
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